The role of nab™-paclitaxel in managing metastatic breast cancer: a report of three casesDAVIDSON, Neville.European journal of cancer. Supplement (1990). 2010, Vol 8, Num 1, pp 11-18, issn 1359-6349, 8 p.Article

Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancerDOUILLARD, Jean-Yves; HOFF, Paulo M; BENNER, Steven E et al.Journal of clinical oncology. 2002, Vol 20, Num 17, pp 3605-3616, issn 0732-183XArticle

Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancerRANSON, Malcolm; DAVIDSON, Neville; WASHINGTON, Terri et al.Journal of the National Cancer Institute. 2000, Vol 92, Num 13, pp 1074-1080, issn 0027-8874Article

Phase II Pilot Study of Intravenous High-Dose Interferon With or Without Maintenance Treatment in Melanoma at High Risk of RecurrencePAYNE, Miranda J; ARGYROPOULOU, Katerina; WELLMAN, Sandie et al.Journal of clinical oncology. 2014, Vol 32, Num 3, pp 185-190, issn 0732-183X, 6 p.Article

Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil- based paclitaxel in women with breast cancerGRADISHAR, William J; TJULANDIN, Sergei; DAVIDSON, Neville et al.Journal of clinical oncology. 2005, Vol 23, Num 31, pp 7794-7803, issn 0732-183X, 10 p.Article

Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination Versus Observation After Resection of Primary Tumor > 1.5 mm in Patients With Stage II Melanoma: Results of the EORTC 18961 Randomized Phase III TrialEGGERMONT, Alexander M. M; SUCIU, Stefan; BASTHOLT, Lars et al.Journal of clinical oncology. 2013, Vol 31, Num 30, pp 3831-3837, issn 0732-183X, 7 p.Article

Effective Inhibition of Aromatase Inhibitor-associated Bone Loss by Zoledronic Acid in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole : ZO-FAST Study ResultsBUNDRED, Nigel J; CAMPBELL, Ian D; COLEMAN, Robert E et al.Cancer. 2008, Vol 112, Num 5, pp 1001-1010, issn 0008-543X, 10 p.Article

Clinical evidence for topotecan-paclitaxel non-cross-resistance in ovarian cancerGORE, Martin; TEN BOKKEL HUININK, Wim; MALFETANO, John et al.Journal of clinical oncology. 2001, Vol 19, Num 7, pp 1893-1900, issn 0732-183XArticle

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic MelanomaROBERT, Caroline; THOMAS, Luc; DAVIDSON, Neville et al.The New England journal of medicine. 2011, Vol 364, Num 26, pp 2517-2526, issn 0028-4793, 10 p.Article

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab : updated efficacy and biomarker analysesCAMERON, David; CASEY, Michelle; CHAN, Arlene et al.Breast cancer research and treatment. 2008, Vol 112, Num 3, pp 533-543, issn 0167-6806, 11 p.Article

Albumin-bound paclitaxel : In metastatic breast cancer. CommentaryROBINSON, Dean M; KEATING, Gillian M; DAVIDSON, Neville et al.Drugs (Basel). 2006, Vol 66, Num 7, pp 941-950, issn 0012-6667, 10 p.Article

Phase III Trial of Sunitinib in Combination With Capecitabine Versus Capecitabine Monotherapy for the Treatment of Patients With Pretreated Metastatic Breast CancerCROWN, John P; DIERAS, Véronique; GREIL, Richard et al.Journal of clinical oncology. 2013, Vol 31, Num 23, pp 2870-2878, issn 0732-183X, 9 p.Article

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)PATEL, Poulam M; SUCIU, Stefan; BECKER, Juergen et al.European journal of cancer (1990). 2011, Vol 47, Num 10, pp 1476-1483, issn 0959-8049, 8 p.Article

Lapatinib plus capecitabine for HER2-positive advanced breast cancerGEYER, Charles E; FORSTER, John; SKARLOS, Dimosthenis et al.The New England journal of medicine. 2006, Vol 355, Num 26, pp 2733-2743, issn 0028-4793, 11 p.Article